Influenza Diagnostics Market 2022 – By Traditional Diagnostic Tests (Rapid Influenza Diagnostics Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests), By Molecular Diagnostic Tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End-User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2031 

Starting Price : $5000.00 | Pages : 302 | Published : June 2022 | SKU CODE : o&s494 | | Format :

Request Sample

Influenza Diagnostics Market Definition

The influenza diagnostics market consists of sales of diagnostic tests and related services by entities (organizations, sole traders and partnerships) that are used to detect and to diagnose influenza. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue and headache.

Influenza Diagnostics Market Size

The global influenza diagnostics market reached a value of nearly $2,269.5 million in 2021, having increased at a compound annual growth rate (CAGR) of 16.5% since 2016. The global influenza diagnostics market size is expected to grow from $2,269.5 million in 2021 to $3,154.6 million in 2026 at a rate of 6.8%. The global influenza diagnostics market size is then expected to grow at a CAGR of 6.8% from 2026 and reach $4,374.5 million in 2031.

Growth in the historic period resulted from a rise in initiatives towards influenza, increased healthcare expenditure, rising air pollution levels, strong economic growth in emerging markets and increased aging population. Factors that negatively affected growth in the historic period were low healthcare access.

Going forward, a rise in healthcare expenditure, increasing government support and increasing FDA approvals for influenza testing will drive market growth. Factors that could hinder the growth of the influenza diagnostics market in the future include a rise in interest rates, lack of healthcare infrastructure and false results.

Influenza Diagnostics Market Drivers

The key drivers of the influenza diagnostics market include:

Rise In Healthcare Expenditure

Increasing healthcare expenditure is predicted to drive the demand for influenza diagnostics. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical & clinical services, thereby driving the influenza diagnostics market. According to the National Health Expenditure Projections 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Furthermore, prescription drug spending is projected to grow by 6.1% annually during 2020-2027.  Consequently, the rise in healthcare spending will increase the demand for influenza diagnostics in the near future.

Influenza Diagnostics Market Restraints

The key restraints on the influenza diagnostics market include:

Lack Of Healthcare Infrastructure

Lack of adequate healthcare infrastructure especially in low income and middle-income countries is expected to limit the growth of the market for influenza diagnostics during the period. Influenza diagnostic development and trails require infrastructure that facilitates electronic exchange of medical information between patients and other stakeholders such as physicians, and research institutions. These systems require a well-developed IT infrastructure to help connect several stakeholders in the healthcare ecosystem including physicians, diagnostic companies, care providers, pharmaceuticals companies, and healthcare companies. Lack of sufficient healthcare IT infrastructure especially in low-income countries could restrain the market in the forecast period.

Influenza Diagnostics Market Trends

Major trends shaping the influenza diagnostics market include:

Use Of Artificial Intelligence

Artificial Intelligence is being increasingly incorporated with rapid diagnostic test kits to increase the efficiency of diagnosis. Artificial intelligence (AI) refers to the simulation of human intelligence in computer-controlled machines that are programmed to perform tasks, which usually require human intelligence. Artificial Intelligence algorithms are being used to integrate the findings of clinical symptoms, exposure history, and laboratory testing to increase the chance of early detection of influenza infection. For instance, in July 2021, AI diagnostics startup MediCircle Health had introduced in India a rapid spectrometry-based test that employs machine learning and artificial intelligence (AI) to detect COVID-19. The enhancements of the product will enable the AI diagnostic solution to test for other diseases such as influenza, tuberculosis, malaria, dengue, UTIs and even sickle cell disease.

Strategic Partnerships and Acquisitions

Mergers and acquisitions are a trend that is expected to impact the influenza diagnostics market positively. Mergers and acquisitions help the companies mobilize resources and get access to various products that are already developed and in research. This helps improve the overall product portfolio and helps get access to broader geographical markets. The diagnostic testing kit manufacturing companies are establishing strategic partnerships with multinational companies for the commercialization and marketing of their products due to the presence of a wide customer base and network. For instance, in May 2021, Roche, a Swiss multinational healthcare company, announced the acquisition of GenMark Diagnostics for $1.8 billion. Roche through the acquisition intended to use GenMark’s expertise in syndromic testing to increase its portfolio of molecular diagnostics. Roche’s portfolio of COVID-19 diagnostic solutions would be complemented by GenMark’s offerings of its Respiratory Pathogen Panel to identify respiratory infections including SARS-CoV-2 and influenza.

Opportunities And Recommendations In The Influenza Diagnostics Market

Opportunities –The top opportunities in the influenza diagnostic market segmented by traditional diagnostic tests will arise in the rapid influenza diagnostic tests (RIDT) segment, which will gain $347.4 million of global annual sales by 2026. The top opportunities in the influenza diagnostic market segmented by molecular diagnostic tests will arise in the reverse transcription polymerase chain reaction (RT-PCR) segment, which will gain $337.2 million of global annual sales by 2026. The top opportunities in the influenza diagnostic market segmented by end user will arise in the hospitals & clinical laboratories segment, which will gain $364.2 million of global annual sales by 2026. The influenza diagnostic market size will gain the most in the USA at $261.7 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the influenza diagnostics companies to focus on smartphone diagnostic apps, focus on expansion through collaborations, focus on technological improvement, establish operations in emerging markets, leverage growth in online sales post COVID-19, provide competitively priced offerings in low-income countries, focus on partnerships with end-users, leverage social media to maximize reach and focus on hospitals and other diagnostic centers.

Influenza Diagnostics Market Segmentation

The influenza diagnostics market is segmented by traditional diagnostic tests, by molecular diagnostic tests and by end-user.
By Traditional Diagnostic Tests –
The influenza diagnostics market is segmented by traditional diagnostic tests into
    • a) Rapid Influenza Diagnostics Tests (RIDT)
    • b) Viral Culture
    • c) DFA
    • d) Serological Assays
    • e) Other Traditional Diagnostic Tests
The rapid influenza diagnostics tests (RIDT) market was the largest segment of the influenza diagnostics market by traditional diagnostic tests, accounting for 40.2% of the total in 2021 and viral culture segment is expected to be the fastest growing segment going forward, at a CAGR of 6.5% during 2021-2026.
The influenza diagnostics market is segmented by molecular diagnostic tests into
    • a) Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • b) Isothermal Nucleic Acid Amplification Tests (INAAT)
    • c) Loop Mediated Isothermal Based Amplification Assays
    • d) Transcription Mediated Isothermal Based Amplification Assays
    • e) Other Isothermal Nucleic Acid Amplification Tests
    • f) Others
The reverse transcription polymerase chain reaction (RT-PCR) market was the largest segment of the influenza diagnostics market by molecular diagnostic tests, accounting for 36.0% of the total in 2021 and is expected to be the fastest growing segment going forward, at a CAGR of 8.1% during 2021-2026.
By End-User –
The influenza diagnostics market is segmented by end-user into
    • a) Hospitals And Clinical Laboratories
    • b) Diagnostic Reference Laboratories
    • c) Academic/Research Institutes
    • d) Other End Users
The influenza diagnostic market is segmented by end user into hospitals and clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users. The hospitals and clinical laboratories market was the largest segment of the influenza diagnostic market segmented by end-user, accounting for 42.6% of the total in 2021 and diagnostic reference laboratories segment is expected to be the fastest growing segment going forward, at a CAGR of 7.1% during 2021-2026.
By Geography - The influenza diagnostics market is segment by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the global influenza diagnostics market, accounting for 34.1% of the total in 2021. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the influenza diagnostic market will be South America and Asia Pacific, where growth will be at CAGRs of 8.3% and 7.4% respectively. These will be followed by North America and Western Europe, where the markets are expected to grow at CAGRs of 6.6% and 6.5% respectively, during 2021-2026.

Influenza Diagnostics Market Competitive Landscape

Major Competitors are:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Quidel Corp
  • Other Competitors Include:

  • Danaher Corporation (Cepheid)
  • Hologic Inc
  • DiaSorin S.p.A
  • GenMark Diagnostics, Inc
  • BioMerieux SA
  • Altona Diagnostics GmbH
  • Siemens Healthineers AG
  • Guangzhou Kingmed Diagnostics Group Co., Ltd
  • Harbin Fuerjia Technology Co., Ltd
  • Shanghai Labway Clinical Laboratory Co., Ltd
  • Shijiazhuang Yipai Biotechnology Co., Ltd
  • BioNTech
  • Pfizer
  • QIAGEN
  • Evotec
  • Morphosys
  • ELITech Group
  • Coris Bioconcept SPRL
  • Mast Group Ltd
  • Anwa-Tech Company
  • HELIMED Diagnostic
  • Medicalogrithmics
  • AeskuLab k.s
  • SPADIA LAB, a.s
  • Zdravotni ustav se sidlem v Usti nad Labem
  • Bio-Rad Laboratories
  • Meridian Bioscience, Inc
  • Clinica San Pablo S.A.C
  • Laboratorios Roe S.A
  • Unilabs Production Services S.A.C
  • Synlab Peu S.A.C
  • Diagnosticos da America S.A. (DASA)
  • Fleury S.A
  • Centro de Imagem Diagnosticos S.A. (Alliar)
  • Instituto Hermes Pardini S.A
  • NMC Healthcare
  • Al-Noor Medical Company
  • VPS Healthcare
  • Tumbay Group
  • Al-Zahra Group
  • Belhoul Lifecare
  • Emirates Healthcare
  • Gulf Healthcare International
  • Gulf Medical Projects Company
  • Zulekha Hospital
  • Saudi German Hospital Group
  • GE Healthcare
  • Aster DM Healthcare
  • Organic Chemistry Laboratory
  • AstraZeneca’s MedImmune unit
  • CSL
  • GlaxoSmithKline Plc
  • Novartis AG
  • Sanofi-Aventis SA
    1. Table Of Contents

      1. Influenza Diagnostics Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1.1. Segmentation By Geography

      6.1.2. Segmentation By Traditional Diagnostic Tests

      6.1.3. Segmentation By Molecular Diagnostic Tests

      6.1.4. Segmentation By End-User

      7. Influenza Diagnostics Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Traditional Diagnostic Tests

      7.2.1. Rapid Influenza Diagnostic Tests (RIDT)

      7.2.2. Viral Culture

      7.2.3. DFA

      7.2.4. Serological Assays

      7.2.5. Others

      7.3. Segmentation By Molecular Diagnostic Tests

      7.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)

      7.3.2. Isothermal Nucleic Acid Amplification Test

      7.3.3. Loop-Mediated Isothermal Based Amplification Assays (LAMP)

      7.3.4. Transcription Mediated Isothermal Based Amplification Assays

      7.3.5. Other Isothermal Nucleic Acid Amplification Tests

      7.4. Segmentation By End User

      7.4.1. Hospitals and Clinical Laboratories

      7.4.2. Diagnostic Reference Laboratories

      7.4.3. Academic/Research Institutes

      7.4.4. Others

      8. Influenza Diagnostics Market Trends And Strategies

      8.1. Strategic Partnerships and Acquisitions

      8.2. Use Of Artificial Intelligence

      8.3. Collaborations Between Governments And Manufacturers

      8.4. At-Home Test Kits

      8.5. Supportive Government Funding and Initiatives

      9. Impact Of COVID-19 On Influenza Diagnostics Market

      9.1. Introduction

      9.2. Impact on Influenza Diagnostic Testing

      9.3. Promotion Of Flu Vaccination During The COVID-19 Pandemic

      9.4. Impact On Companies Revenue

      9.5. Future Outlook

      10. Global Influenza Diagnostics Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      10.2.1. Drivers Of The Market 2016 – 2021

      10.2.2. Restraints On The Market 2016 – 2021

      10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      10.3.1. Drivers Of The Market 2021 – 2026

      10.3.2. Restraints On The Market 2021 – 2026

      11. Global Influenza Diagnostics Market Segmentation

      11.1. Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.2. Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.3. Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Influenza Diagnostics Market, Regional And Country Analysis

      12.1. Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.2. Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Asia-Pacific Influenza Diagnostics Market

      13.1. Asia-Pacific Influenza Diagnostics Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.3. Asia-Pacific Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.4. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.5. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. China Influenza Diagnostics Market

      13.7. China Influenza Diagnostics Market Overview

      13.7.1. Country Information

      13.7.2. Market Information

      13.7.3. Background Information

      13.7.4. Government Initiatives

      13.7.5. Regulations

      13.7.6. Regulatory Bodies

      13.7.7. Major Associations

      13.7.8. Taxes Levied

      13.7.9. Corporate Tax Structure

      13.7.10. Investments

      13.7.11. Major Companies

      13.8. China Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.9. China Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.10. China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.11. China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. India Influenza Diagnostics Market

      13.13. India Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.14. India Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.15. India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.16. India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.17. Japan Influenza Diagnostics Market

      13.18. Japan Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.19. Japan Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.20. Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.21. Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.22. Australia Influenza Diagnostics Market

      13.23. Australia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.24. Australia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.25. Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.26. Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.27. Indonesia Influenza Diagnostics Market

      13.28. Indonesia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.29. Indonesia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.30. Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.31. Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.32. South Korea Influenza Diagnostics Market

      13.33. South Korea Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.34. South Korea Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.35. South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.36. South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. Western Europe Influenza Diagnostics Market

      14.1. Western Europe Influenza Diagnostics Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.3. Western Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.4. Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.5. Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. Western Europe Influenza Diagnostics Market: Country Analysis

      14.7. UK Influenza Diagnostics Market

      14.8. UK Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.9. UK Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.10. UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.11. UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.12. Germany Influenza Diagnostics Market

      14.13. Germany Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.14. Germany Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.15. Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.16. Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.17. France Influenza Diagnostics Market

      14.18. France Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.19. France Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.20. France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.21. France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. Eastern Europe Influenza Diagnostics Market

      15.1. Eastern Europe Influenza Diagnostics Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.3. Eastern Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.4. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.5. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. Eastern Europe Influenza Diagnostics Market: Country Analysis

      15.7. Russia Influenza Diagnostics Market

      15.8. Russia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.9. Russia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.10. Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.11. Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. North America Influenza Diagnostics Market

      16.1. North America Influenza Diagnostics Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulatory Bodies

      16.1.6. Regulations

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate tax structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.3. North America Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.4. North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.5. North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. USA Influenza Diagnostics Market

      16.7. USA Influenza Diagnostics Market Overview

      16.7.1. Country Information

      16.7.2. Market Information

      16.7.3. Background Information

      16.7.4. Government Initiatives

      16.7.5. Regulatory Bodies

      16.7.6. Regulations

      16.7.7. Major Associations

      16.7.8. Taxes Levied

      16.7.9. Corporate Tax Structure

      16.7.10. Investments

      16.7.11. Major Companies

      16.8. USA Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.9. USA Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.10. USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.11. USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. South America Influenza Diagnostics Market

      17.1. South America Influenza Diagnostics Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.3. South America Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.4. South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.6. South America Influenza Diagnostics Market: Country Analysis

      17.7. Brazil Influenza Diagnostics Market

      17.8. Brazil Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.9. Brazil Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.10. Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.11. Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Middle East Influenza Diagnostics Market

      18.1. Middle East Influenza Diagnostics Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      18.3. Middle East Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      18.4. Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18.5. Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19. Africa Influenza Diagnostics Market

      19.1. Africa Influenza Diagnostics Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      19.3. Africa Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      19.4. Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19.5. Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      20. Influenza Diagnostics Market Competitive Landscape And Company Profiles

      20.1. Company Profiles

      20.2. Abbott Laboratories

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. F. Hoffmann-La Roche Ltd

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Becton, Dickinson and Company

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Financial Overview

      20.5. Thermo Fisher Scientific Inc

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Quidel Corporation

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Influenza Diagnostics Market

      21.1. Becton, Dickinson and Company Acquired Scanwell Health

      21.2. Roche Acquired TIB Molbiol Group

      21.3. Mylab Discovery Solutions Partnered With Hemex Health

      21.4. Roche Acquired GenMark Diagnostics

      21.5. Hologic Acquired Mobidiag Oy

      21.6. DiaSorin Acquired Luminex

      21.7. Thermo Fisher Acquired Mesa Biotech

      21.8. Becton Dickinson Acquired NAT Diagnostics

      21.9. Meridian Bioscience Inc Acquired GenePoc Inc

      22. Influenza Diagnostics Market Opportunities And Strategies

      22.1. Global Influenza Diagnostics Market In 2026 – Countries Offering Most New Opportunities

      22.2. Global Influenza Diagnostics Market In 2026 – Segments Offering Most New Opportunities

      22.3. Global Influenza Diagnostics Market In 2026 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Influenza Diagnostics Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
    • Table 14: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 17: Asia-Pacific Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 18: Asia-Pacific Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 19: Asia-Pacific Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 20: Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 21: Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 22: Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 23: Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 24: China GDP Per Capita, 2016-2021, $
    • Table 25: China Population By Age Group, 2016-2026, Thousands
    • Table 26:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 27: China Healthcare Services, 2016-2026, $ Billion
    • Table 28: China Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 29: China Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 30: China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 31: China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 32: China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 33: China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 34: India Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 35: India Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 36: India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 37: India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 38: India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 39: India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 40: Japan Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 41: Japan Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 42: Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 43: Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 44: Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 45: Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 46: Australia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 47: Australia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 48: Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 49: Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 50: Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 51: Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 52: Indonesia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 53: Indonesia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 54: Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 55: Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 56: Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 57: Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 58: South Korea Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 59: South Korea Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 60: South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 61: South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 62: South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 63: South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 64: Western Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 65: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 66:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 67:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 68: Western Europe Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 69: Western Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 70: Western Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 71: Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 72: Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 73: Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 74: Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 75: UK Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 76: UK Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 77: UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 78: UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 79: UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 80: UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 81: Germany Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 82: Germany Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 83: Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 84: Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 85: Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 86: Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 87: France Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 88: France Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 89: France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 90: France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 91: France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 92: France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 93: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
    • Table 94: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 95:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 96:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 97: Eastern Europe Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 98: Eastern Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 99: Eastern Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 100: Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 101: Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 102: Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 103: Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 104: Russia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 105: Russia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 106: Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 107: Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 108: Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 109: Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 110: North America GDP Per Capita, By Country, 2016-2021, $
    • Table 111: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 112:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 113:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 114: North America Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 115: North America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 116: North America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 117: North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 118: North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 119: North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 120: North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 121: USA GDP Per Capita, 2016-2021, $
    • Table 122: USA Population By Age Group, 2016-2026, Thousands
    • Table 123:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 124: USA Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 125: USA Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 126: USA Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 127: USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 128: USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 129: USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 130: USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 131: South America GDP Per Capita, By Country, 2016-2021, $
    • Table 132: South America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 133:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 134:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 135: South America Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 136: South America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 137: South America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 138: South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 139: South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 140: South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 141: South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 142: Brazil Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 143: Brazil Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 144: Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 145: Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 146: Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 147: Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 148: Middle East GDP Per Capita, By Country, 2016-2021, $
    • Table 149: Middle East Population By Age Group, By Country, 2016-2026, Thousands
    • Table 150:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 151:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 152: Middle East Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 153: Middle East Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 154: Middle East Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 155: Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 156: Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 157: Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 158: Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 159: Africa GDP Per Capita, By Country, 2016-2021, $
    • Table 160: Africa Population By Age Group, By Country, 2016-2026, Thousands
    • Table 161:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 162:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 163: Africa Healthcare Services, By Country, 2016-2026, $ Billion
    • Table 164: Africa Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Table 165: Africa Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 166: Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 167: Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 168: Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 169: Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 170: Global Influenza Diagnostics market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 171: Abbott – Financial Performance, $ Billion
    • Table 172: Roche – Financial Performance, $ Billion
    • Table 173: BD – Financial Performance, $ Billion
    • Table 174: Thermo Fisher– Financial Performance, $ Billion
    • Table 175: Quidel – Financial Performance, $ Billion
    • Table 176: Global Influenza Diagnostics Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 177: Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By Traditional Diagnostic Tests, 2021 – 2026
    • Table 178: Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By Molecular Diagnostic Tests, 2021 – 2026
    • Table 179: Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By End-User, 2021 – 2026
    • Table 180: Influenza Diagnostics - Market Data Sources

    List Of Figures

      Figure 1: Global Influenza Diagnostics Market Segmentation By Traditional Diagnostic Tests
    • Figure 2: Global Influenza Diagnostics Market Segmentation By Molecular Diagnostic Tests
    • Figure 3: Global Influenza Diagnostics Market Segmentation By End-User
    • Figure 4: Global Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 5: Global Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 6: Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 7: Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 8: Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Asia-Pacific Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 12: Asia-Pacific Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 13: Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 14: Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 15: China Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 16: China Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 17: China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 18: China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 19: India Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 20: India Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 21: India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 22: India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: Japan Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 24: Japan Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 25: Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 26: Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 27: Australia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 28: Australia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 29: Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 30: Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 31: Indonesia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 32: Indonesia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 33: Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 34: Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: South Korea Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 36: South Korea Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 37: South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 38: South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 39: Western Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 40: Western Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 41: Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 42: Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 43: UK Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 44: UK Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 45: UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 46: UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 47: Germany Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 48: Germany Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 49: Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 50: Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 51: France Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 52: France Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 53: France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 54: France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 55: Eastern Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 56: Eastern Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 57: Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 58: Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 59: Russia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 60: Russia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 61: Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 62: Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 63: North America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 64: North America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 65: North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 66: North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 67: USA Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 68: USA Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 69: USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 70: USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 71: South America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 72: South America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 73: South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 74: South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 75: Brazil Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 76: Brazil Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 77: Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 78: Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 79: Middle East Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 80: Middle East Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 81: Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 82: Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 83: Africa Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
    • Figure 84: Africa Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 85: Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 86: Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 87: Global Influenza Diagnostics market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 88: Abbott – Financial Performance, $ Billion
    • Figure 89: Roche – Financial Performance, $ Billion
    • Figure 90: BD – Financial Performance, $ Billion
    • Figure 91: Thermo Fisher– Financial Performance, $ Billion
    • Figure 92: Quidel – Financial Performance, $ Billion
    Global Foot And Ankle Devices Market Outlook, Opportunities And Strategies – Includes Foot And Ankle Devices Market Trends
    Global 3D Orthpedics/Prosthetics Market Outlook, Opportunities And Strategies – includes 3D Orthpedics/Prosthetics Market Analysis
    Global Continuous Blood Glucose Monitoring Market Outlook, Opportunities And Strategies – Includes Continuous Blood Glucose Monitoring Market Size
    Global Medical Device Outsourcing Market Outlook, Opportunities And Strategies – Includes Medical Device Outsourcing Market Growth
    Global Anesthesia Monitoring Devices Market Size, Forecasts, And Opportunities – Includes Anesthesia Monitoring Devices Market Forecast
    Global Cranial Implants Market Size, Forecasts, And Opportunities – Including Cranial Implants Market Share And Market Players
    Global Digital Therapeutics Market Overview And Prospects – Including Digital Therapeutics Market Size
    Global Interventional Radiology Market Outlook, Opportunities And Strategies – Including Interventional Radiology Market Trends And Leading Competitors’
    Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare Settings), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, Small Joint Surgery), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Sterilization Equipment and Disinfectants Market - By Type Of Products (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End User (Hospitals And Clinics, Clinical Laboratories, Pharmaceutical Companies, Non-Industrial Use ), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report
    Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD), By End-Use (Hospitals, Clinical Laboratories, Home Care), Opportunities And Strategies - Global Forecast To 2030
    View Report
    Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report
    Breast Imaging Devices Global Market Report 2022 – By Product Type (Tomosynthesis, Breast Ultrasound, Breast MRI, Mammography, Nuclear Imaging, Other Product Types), By Technology (Ionizing, Non Ionizing), By End User (Hospitals & Clinics, Breast Care Centers, Diagnostic Imaging Centers) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Robotic Surgery Devices Global Market Report 2022 – By Product and Service (Robotic systems, Instruments & Accessories, Services), By Surgery Type (Urological surgery, Gynecological surgery, Orthopedic surgery, Neurosurgery, Other Surgery Types), By End User (Hospitals, Ambulatory Surgery Centers) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Breast Cancer Diagnostics Global Market Report 2022 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC)), By Cancer Type (BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer), By Diagnostic Type (Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies), By End-User (Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2022-2026
    View Report